Clinical Trial Update: Neoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal Sarcoma [Phase 4]

View source ↗

Summary

A Phase 4 trial updating neoadjuvant chemotherapy combined with targeted therapy for high-risk retroperitoneal sarcoma is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retroperitoneal Sarcoma

Snippet

Sponsor: Peking University International Hospital | Conditions: Retroperitoneal Sarcoma | Phase 4 | Status: ENROLLING_BY_INVITATION